1. [Construction, expression and immunogenicity analysis of a Tat N-terminus-deleted mutant fusion protein of human immunodeficiency virus type 1].
- Author
-
Zhang HQ, Liao WT, Chen QL, Ge YB, Yang J, Zhang PP, Qi PP, Liu C, He T, Wang JH, Pan W, and Cao J
- Subjects
- Animals, Female, Gene Products, tat biosynthesis, Gene Products, tat immunology, Humans, Mice, Mice, Inbred BALB C, Mutant Proteins immunology, Recombinant Fusion Proteins biosynthesis, Recombinant Fusion Proteins immunology, Gene Products, tat genetics, HIV-1 genetics, HIV-1 immunology, Mutant Proteins genetics, Recombinant Fusion Proteins genetics
- Abstract
In the study, a gene encoding Tat protein N terminal 1- 21 amino acid residues-deleted mutant (Tat22-101) was amplified by PCR from a full length Tat gene of human immunodeficiency virus type 1, and the prokaryotic expression plasmid pET32a-Tat22-101 was constructed. After identification by digestion with endonucleases and sequencing, the recombinant plasmid pET32a-Tat22-101 was transformed into E. coli BL21(DE3) and expressed with IPTG induction. The mutant fusion protein with deleted Tat N terminal was purified by an affinity chromatography column Ni(2+)-NTA and subsequently identified by SDS-PAGE and Western blotting. The results showed that the molecular weight of the mutant protein was approximately 26.9kD. Furthermore, BALB/c mice were immunized with the mutant protein and the anti-sera were collected. ELISA results showed that the mutant protein preserved its immunogenicity, particularly it could improve the production of antibodies to other epitopes in addition to the N terminal epitope of Tat protein, which might provide some valuable information for the study of Tat functions as well as for development of potential novel HIV Tat vaccine.
- Published
- 2011